Sales & Marketing The scattered seeds of the beginnings of change - a pharmaph... Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and
News BI, Click Therapeutics expand collaboration to PDT for schiz... Boehringer Ingelheim (BI) and Click Therapeutics have announced they are expanding their
News Regeneron, CytomX announce bispecific therapeutics for cance... Regeneron Pharmaceuticals, Inc. and CytomX Therapeutics, Inc.
Market Access Philips on designing innovation and cultivating partnerships... This article follows part one of our
Sales & Marketing Preparing for a post-pandemic world Janssen’s Mark Hicken, VP of strategy, EMEA, looks at what COVID-19 has taught us and how we can become stronger as we emerge from the pandemic.
Views & Analysis The new pharma collaborations driving transformative researc... The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.